Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT
Publication date
2025-01
Authors
Angelillo, Piera
Alarcon Tomas, Ana
Campodonico, Edoardo
Novak, Urban
Gabellier, Ludovic
Blau, Igor Wolfgang
Kwon, Mi
Ram, Ron
Forcade, Edouard
Besley, Caroline
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Letter
Citation
Angelillo, P, Alarcon Tomas, A, Campodonico, E, Novak, U, Gabellier, L, Blau, I W, Kwon, M, Ram, R, Forcade, E, Besley, C, Vucinic, V, Kröger, N, Corral, L L, Vydra, J, Ferrari, S, von Tresckow, B, Rubio, M T, Hernani, R, Sica, S, Stölzel, F, Rovira, M, Wagner-Drouet, E, Pérez-Simón, J A, Castilla-Llorente, C, Ferreri, A J M, Hoogenboom, J D, Sanchez Ortega, I, Malard, F, Kuball, J & Ruggeri, A 2025, 'Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe : a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT', Bone Marrow Transplantation, vol. 60, no. 1, pp. 100-102. https://doi.org/10.1038/s41409-024-02451-8